LABCORP HOLDINGS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of the members of the Company's Board of Directors: Adam H. Schechter

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Adam H. Schechter”): 64,389,315 for, 5,641,829 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,781,542 for, 64,535 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D.

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: D. Gary Gilliland, M.D., Ph.D.”): 68,294,395 for, 1,740,958 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,799,652 for, 46,425 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D.

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Garheng Kong, M.D., Ph.D.”): 66,640,297 for, 3,395,578 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,780,799 for, 65,278 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Jeffrey A. Davis

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Jeffrey A. Davis”): 69,463,722 for, 567,927 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,834,164 for, 11,913 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kathryn E. Wengel

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Kathryn E. Wengel”): 69,575,928 for, 456,453 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,842,556 for, 1,794 against, 13,675 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kerrii B. Anderson

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Kerrii B. Anderson”): 66,488,913 for, 3,508,186 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,741,267 for, 103,083 against, 13,675 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Kirsten M. Kliphouse”): 69,995,119 for, 38,059 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,844,350 for, 0 against, 13,675 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D.

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Paul B. Rothman, M.D.”): 69,718,513 for, 315,012 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,842,556 for, 3,521 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Peter M. Neupert

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Peter M. Neupert”): 66,721,361 for, 3,311,045 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 30,725,120 for, 1,120,957 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Richelle P. Parham

LABCORP HOLDINGS INC.’s own tally for this item (“Elect Director: Richelle P. Parham”): 66,976,123 for, 3,024,056 against, per its Form 8-K filed May 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2026 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 31,826,046 for, 20,031 against, 11,948 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: TO APPROVE THE COMPANY'S 2025 OMNIBUS INCENTIVE PLAN.

LABCORP HOLDINGS INC.’s own tally for this item (“3. The adoption of the 2025 Omnibus Incentive Plan and certain material terms and conditions relating to performance-based compensation under the 2025 Omnibus Incentive Plan”): 65,957,167 for, 3,916,664 against — passed, per its Form 8-K filed May 20, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved the adoption of the 2025 Omnibus Incentive Plan and certain material terms and conditions relating to performance-based compensation under the 2025 Omnibus Incentive Plan.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 152 managers: 30,220,261 for, 1,614,147 against, 0 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 11 managers: 1,063,835 for, 3,773 against.

The 154 asset managers below reported 31,806,499 for, 11,948 against, 0 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 154 asset managers. See all 154 in the interactive database.

Description as filed by funds: To approve, by non-binding vote, the compensation of the Company's Named Executive Officers.

LABCORP HOLDINGS INC.’s own tally for this item (“2. In an advisory (non-binding) vote, the compensation of the Company's named executive officers”): 64,147,316 for, 5,634,146 against — passed, per its Form 8-K filed May 20, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved in an advisory (non-binding) vote, the compensation of the Company's named executive officers.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of LABCORP HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Section 14a Executive Compensation” (12 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 153 managers: 31,407,704 for, 415,330 against, 11,948 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 782 managers: 38,686,999 for, 4,350,852 against, 93,291 abstained, 19,395 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2025.

LABCORP HOLDINGS INC.’s own tally for this item (“5. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 75,696,303 for, 297,066 against — passed, per its Form 8-K filed May 20, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 31,848,755 for, 2,417 against, 11,948 abstained.

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.